PRESS RELEASES
EPIVAX THERAPEUTICS APPOINTS NICOLE RUGGIERO AS CHIEF EXECUTIVE OFFICER AND GUILHEM RICHARD AS CHIEF TECHNOLOGY OFFICER
March 29, 2022
EpiVax Therapeutics is excited to announce the appointment of Nicole Ruggiero as Chief Executive Officer and Guilhem Richard as Chief Technology Officer.